BR Shetty fraud trial opens in 2026, six years after NMC Health's $6.6bn collapse

BR Shetty's criminal fraud trial opened on 26 March 2026, six years after NMC Health's collapse under $6.6 billion in concealed debt — the largest healthcare insolvency in Middle East history. Shetty founded NMC from a single Abu Dhabi pharmacy in 1975 and built it into a FTSE 100 constituent before the group imploded in early 2020, wiping out thousands of creditors.

What the prosecution alleges

The case centres on allegations that Shetty and associates systematically falsified NMC Health's financial statements, concealing debt and inflating asset valuations to mislead shareholders and lenders. Prosecutors allege the scheme defrauded more than 80 banks globally, including several UAE-headquartered institutions.

Shetty has denied orchestrating the fraud, pointing to other executives and advisers. His defence team is expected to argue that he was misled by subordinates who managed day-to-day finances. The trial is projected to run for several months given the volume of financial documentation involved.

The collapse and its aftermath

NMC entered administration in April 2020 after short-seller Muddy Waters Research published a report in December 2019 questioning the accuracy of its cash balances. Subsequent investigations by administrators at Alvarez & Marsal uncovered debt that had not appeared in audited accounts. At its peak, NMC operated across 19 countries with:

• More than 200 facilities
• Approximately 35,000 staff
• More than 80 creditor banks globally
• A FTSE 100 listing on the London Stock Exchange

The collapse disrupted UAE healthcare delivery across multiple Emirates. Facilities were placed under emergency oversight, staff payroll was interrupted, and the Department of Health Abu Dhabi (DOH) stepped in to maintain patient care at NMC's Abu Dhabi network. The Dubai Health Authority (DHA) took parallel steps to monitor NMC-licensed clinics during the administration period.

Creditors recovered a fraction of their exposure. A restructured entity, NMC Healthcare, emerged from administration in 2022 under new ownership, retaining core UAE operations at a significantly reduced footprint.

What this means for healthcare operators

The trial arrives as regulators across the UAE have tightened disclosure requirements for healthcare groups. The DOH introduced enhanced financial reporting obligations for licensed hospital operators in Abu Dhabi in 2023, citing the need for transparency in group-level debt structures. The DHA's licensing framework for large multi-site operators now includes periodic financial health attestations.

For private equity-backed and publicly listed healthcare groups in the UAE, the case exposes a structural risk: individual clinic licences can remain technically valid even as a holding company is insolvent, a gap that Alvarez & Marsal flagged during the NMC administration and that regulators have since moved to close.

The outcome will be closely watched by the UAE Securities and Commodities Authority, which has been developing stricter guidelines on cross-border listed entities with significant UAE healthcare assets. A conviction would likely accelerate calls for mandatory real-time debt disclosure for FTSE or regional exchange-listed operators running UAE-licensed facilities.